$24.61

-0.09 (-0.36%)

Weekly Expected Move ±0.3%

$25 $25 $25 $25 $25

NYSE · Healthcare · Medical - Devices · Alpha Radar Neutral · Power 50 · $1.2B mcap · 45M float · 2.92% daily turnover · Short 29% of daily vol

Revenue

$701M +1.9% ▲

5Y CAGR: -0.4%

Gross Profit

$349M -8.5% ▼

5Y CAGR: -2.2%

Operating Income

-$62M -254.0% ▼

Net Income

-$68M +82.7% ▲

EPS (Diluted)

$-1.46 +82.9% ▲

EBITDA

-$33M +90.4% ▲

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$745M	$684M	$673M	$688M	$701M
YoY Growth	+4.2%	-8.1%	-1.6%	+2.2%	+1.9%
Cost of Revenue	$365M	$290M	$294M	$306M	$352M
Gross Profit	$380M	$394M	$380M	$381M	$349M
Gross Margin	51.0%	57.6%	56.4%	55.4%	49.8%
R&D Expenses	$32M	$31M	$27M	$26M	$23M
SG&A Expenses	$261M	$323M	$288M	$315M	$218M
Operating Expenses	$293M	$352M	$315M	$341M	$411M
Operating Income	$87M	$42M	$65M	$40M	-$62M
Operating Margin	11.7%	6.1%	9.7%	5.8%	-8.8%
Interest Expense	$3M	$10M	$15M	$12M	$4M
Income Before Tax	$7M	$27M	-$8M	-$403M	-$66M
Tax Expense	$1M	$5M	$2M	-$17M	$2M
Net Income	$6M	$50M	-$62M	-$392M	-$68M
Net Margin	0.8%	7.4%	-9.2%	-57.0%	-9.7%
EPS (Diluted)	$0.13	$1.07	$-1.33	$-8.53	$-1.46
EBITDA	$49M	$78M	$51M	-$346M	-$33M
Shares Outstanding	49M	47M	47M	46M	46M

Line Item	FY2024 Q2	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1
Revenue	$172M	$170M	$180M	$168M	$175M	$178M	$181M	$182M
Cost of Revenue	$76M	$78M	$80M	$78M	$83M	$97M	$95M	$94M
Gross Profit	$96M	$93M	$99M	$90M	$92M	$81M	$86M	$88M
Gross Margin	55.7%	54.5%	55.3%	53.6%	52.6%	45.6%	47.5%	48.5%
R&D Expenses	$6M	$7M	$6M	$5M	$6M	$6M	$6M	$5M
SG&A Expenses	$73M	$69M	$81M	$77M	$79M	$62M	$78M	$71M
Operating Expenses	$80M	$76M	$87M	$82M	$85M	$68M	$175M	$76M
Operating Income	$16M	$17M	$12M	$7M	$7M	$13M	-$89M	$12M
Operating Margin	9.4%	9.8%	7.0%	4.4%	4.2%	7.4%	-49.4%	6.7%
Interest Expense	$3M	$3M	$3M	$2M	$2M	$2M	$2M	$2M
Income Before Tax	$6M	$10M	-$420M	$10M	-$76M	-$1M	$1M	$8M
Tax Expense	$2M	$4M	-$24M	$3M	$900K	$200K	-$2M	$2M
Net Income	$2M	$4M	-$397M	$7M	-$77M	-$1M	$4M	$5M
Net Margin	1.0%	2.5%	-221.2%	3.9%	-43.9%	-0.8%	2.0%	2.8%
EPS (Diluted)	$0.04	$0.09	$-8.64	$0.14	$-1.66	$-0.03	$0.08	$0.11
EBITDA	$21M	$24M	-$407M	$21M	-$64M	$10M	$13M	$22M
Shares Outstanding	46M	47M	46M	47M	47M	46M	46M	46M

AVNS NYSE